Rockefeller Capital Management L.P. Increases Holdings in Corteva, Inc. $CTVA

Rockefeller Capital Management L.P. increased its position in Corteva, Inc. (NYSE:CTVA) by 40.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 77,349 shares of the company’s stock after buying an additional 22,437 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Corteva were worth $5,185,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of CTVA. JPL Wealth Management LLC purchased a new position in shares of Corteva during the third quarter worth approximately $25,000. Garton & Associates Financial Advisors LLC purchased a new stake in shares of Corteva in the 4th quarter valued at $27,000. Bank of Jackson Hole Trust purchased a new stake in shares of Corteva in the 4th quarter valued at $28,000. Cornerstone Financial Management LLC bought a new position in shares of Corteva during the 4th quarter valued at $29,000. Finally, Basepoint Wealth LLC bought a new position in shares of Corteva during the 4th quarter valued at $30,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Trading Up 1.2%

Shares of CTVA opened at $82.60 on Friday. The stock has a market capitalization of $55.24 billion, a P/E ratio of 48.59, a PEG ratio of 2.50 and a beta of 0.57. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The firm has a fifty day simple moving average of $79.38 and a two-hundred day simple moving average of $76.20. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $85.63.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company’s revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were paid a $0.18 dividend. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 42.35%.

Wall Street Analyst Weigh In

CTVA has been the subject of several recent research reports. Weiss Ratings raised shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, May 7th. Mizuho lifted their price objective on Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, April 15th. Argus lifted their price objective on Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a report on Tuesday, March 31st. Deutsche Bank Aktiengesellschaft boosted their target price on Corteva from $90.00 to $100.00 in a research note on Monday, May 11th. Finally, Jefferies Financial Group raised their price target on Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $88.81.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.